Drug Trial Radar · NCT06736990
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Last checked: Nov 20, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Jun 20, 2025
Primary completion
Nov 2026
Study completion Feb 2027
Sponsor
- Lead sponsor
- Calluna Pharma ASIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the investigational drug CAL101 can help prevent further decline in lung function in adults with Idiopathic Pulmonary Fibrosis. Researchers will compare CAL101 with placebo to compare change from baseline in forced vital capacity (FVC). Participants will be randomly assigned to a study group that will receive an IV infusion of either the study medication or placebo about once a month for 6 months.
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
CAL101Drug
Intravenous infusions of CAL101 every 4 weeks over 24 weeks
PlaceboDrug
Intravenous infusions of placebo every 4 weeks over 24 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in forced vital capacity (FVC) compared to placeboTime frame: 28 weeks
Locations
54 sites in 11 countries. Site status is shown where the registry gives one.
Keck School of Medicine at USC
Los Angeles, California
National Jewish Health
Denver, Colorado
Y & L Advance Health Care, Inc. d/b/a Elite Clinical Research
Miami, Florida
University of Kansas Medical Center
Kansas City, Kansas
Pulmonix, LLC
Greensboro, North Carolina
Southeastern Research Center
Winston-Salem, North Carolina
Cleveland Clinic
Cleveland, Ohio
Temple University Hospital
Philadelphia, Pennsylvania
University of Utah Health
Salt Lake City, Utah
Aarhus University Hospital
Aarhus, Denmark
Rigshospitalet
Copenhagen, Denmark
Odense University Hospital
Odense, Denmark
AP-HP Hopital Avicenne
Bobigny, France
AP-HP Hopital Europeen Georges Pompidou
Paris, France
CHU Rennes - Hopital Pontchaillou
Rennes, France
CHU de Toulouse - Hopital Larrey
Toulouse, France
CHRU de Tours - Hôpital Bretonneau
Tours, France
Azienda Ospedaliero-Universitaria di Modena
Modena, Italy
AORN - Ospedali dei Colli - Ospedale V. Monaldi
Naples, Italy
Istituto Clinico Humanitas - Pneumologia 1
Rozzano, Italy
Azienda Ospedale - Università Padova
Padova, PD, Italy
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore
Roma, RM, Italy
Azienda Ospedaliero Universitaria Senese
Siena, SI, Italy
Azienda sanitaria universitaria Giuliano Isontina (ASU GI) - Ospedale di Cattinara
Trieste, TS, Italy
Erasmus MC
Rotterdam, South Holland, Netherlands
St. Antonius Ziekenhuis - Locatie Nieuwegein
Nieuwegein, Utrecht, Netherlands
Haukeland University Hospital
Bergen, Norway
Akershus University Hospital
Lørenskog, Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway
Institutul de Pneumoftiziologie Marius Nasta
Bucharest, Romania
Spitalul Clinic de Pneumoftiziologie ''Leon Daniello''
Cluj-Napoca, Cluj, Romania
Spitalul Clinic de Boli Infectioase si Pneumoftiziologie ''Victor Babes'' Craiova
Craiova, Dolj, Romania
Spitalul Clinic de Boli Infectioase si Pneumoftiziologie dr. Victor Babes Timisoara
Timișoara, Timiș County, Romania
Seoul National University Bundang Hospital
Gyeonggi-do, South Korea
Seoul National University Hospital
Seoul, South Korea
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Ajou University Hospital
Suwon, Gyeonggi-do, South Korea
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital Universitario Vall d'Hebron
Barcelona, Spain
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.